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mailed to patients within a week of their hospital dis-
charge, with a return rate of approximately 25%. Surveys
from patients whose DRG indicated HIV/AIDS were
selected for further analysis. Groups of patients who were
treated at the same hospitals as the HIV/AIDS sample, but
whose diagnoses were not related to HIV/AIDS, served as
comparisons. RESULTS: HIV/AIDS patients’ ratings 
differed in several respects from those of other patients.
Nursing care, staff concern, and handling of tests/treat-
ments were rated signiﬁcantly (p < .05) worse than those
of comparison patients. But ratings of admission proce-
dures, room amenities, and physician care did not differ
from those of non-HIV/AIDS patients, eliminating
general response bias as an explanation for the ﬁndings.
An index pertaining to how hospitals might improve
quality of care for HIV/AIDS patients showed that they
would gain the most from attending to HIV/AIDS’
patients spiritual and emotional needs; helping them to
arrange home care after discharge, and giving better
explanations about tests and treatments. CONCLU-
SIONS: HIV/AIDS patients’ reported experiences with
hospitalization were worse than those of hospitalized
non-HIV/AIDS patients. Hospital personnel can use spe-
ciﬁc ﬁndings to improve treatment experiences of such
patients.
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OBJECTIVE: To examine the burden of side effects in
patients receiving anti-retroviral therapy METHODS: We
reviewed literature on relationships between side-effects,
adherence and quality of life in HIV infected patients and
developed an exploratory survey to assess impact of side-
effects of anti-retroviral therapy on patient’s lives. We
pilot tested the survey in a small sample of HIV infected
patients. The revised survey was web-enabled and made
accessible to patients through HIV/AIDS web sites. The
survey contained questions on presence of side effects,
their impact on work, social life, family, lifestyle and self-
perception as well as strategies used by patients to
manage their side effects. An exploratory factor analysis
using maximum likelihood estimation and oblique rota-
tion was performed on questions about impact to deter-
mine the latent dimensional structure of “burden” of side
effects as perceived by HIV patients. RESULTS: Four
hundred one respondents (mean age = 43 years, 88%
male) completed the survey. More than 80% of respon-
dents were on regimens with 3 or more anti-retroviral
medications. Fatigue (reported by 64% of respondents),
diarrhea (62%), sleep problems (49%), lipodystrophy
(48%) and sexual dysfunction (44%) were the most com-
monly reported side-effects. More than 80% of patients
indicated that side effects impacted their life at least mod-
erately when reporting impact on a 5-point Likert scale.
To make the side-effects less bothersome 26% reported
skipping or spacing out doses, 50% reported requesting
their physician to change their medication and 20%
reported discontinuing their medication altogether.
Exploratory factor analysis suggested a unidimensional
factor structure accounting for 84% of the variance in
underlying latent trait. CONCLUSIONS: Side effects of
anti-retroviral therapy can impose signiﬁcant humanistic
burden on HIV patients that should be more thoroughly
assessed in clinical trials.
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OBJECTIVES: Acute otitis media (AOM) is a common
pathology in children usually treated with an antibiotic
given 2 or 3 times per day for 10 days. Non-compliance
is often an issue and may explain in part the development
of antimicrobial resistance. We conducted a Willingness
to Pay study (WTP) to identify parents’ preferences and
assess the value given to a unique dose treatment in com-
parison with classical treatments. METHODS: Patients
were accrued between February and November 2002.
The study population was composed of parents of chil-
dren with AOM who were interviewed by phone at the
end of the AOM treatment. The questionnaire included
three main topics: demographic characteristics, past
medical history and history of present illness, quality of
life assessment and treatment compliance. A multivariate
analysis will be performed to estimate the various pre-
dictors of WTP. RESULTS: An analysis was performed
on 595 respondents. Forty-six percent of the children
were <2 years and 33% were between 2 and 5 years of
age. The majority (72%) attended day care center or
school and most had received an antibiotic for AOM in
the previous 6 months (45%). Parents were willing to pay
an average (CAD mean, 95% CI) $31.54 ($29.42–33.65)
for a unique dose treatment (n = 562). The AOM treat-
ment which had been received modiﬁed the parents’ WTP
(Anova, p = 0.016) with azithromycin ¥5 days (n = 102)
producing the smallest value $24.05 (19.75–28.34).
Other treatments produced higher values: $32.31
(29.42–35.20) for amoxicillin (n = 249); $32.83
(22.67–43.00) for amoxicillin-clavulanic acid (n = 60)
and $35.42 (31.47–39.37) for cefprozil (n = 119). 
CONCLUSIONS: Parents of children who received
azithromycin gave the smallest value while those whose
children had received amoxicillin, amoxicillin-clavulanic
acid or cefprozil gave the highest values. Therefore, pre-
viously received antibiotic affects the magnitude of the
WTP which is smaller for parents whose children had
received shorter duration treatment.
